Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The aim of this study is to evaluate the efficacy of pulmonary physiotherapy on respiratory functions in hospitalized patients with Novel Coronavirus 2019 pneumonia. Patients will be randomized into 1) intervention group: receiving pulmonary physiotherapy technique to improve pulmonary function and walking training or 2) control group: Usual medical care. Patients in both groups will receive therapeutic incentive spirometer. Various outcome measurements of pulmonary functions will be evaluated before and after of interventions. Mortality rate, hospitalization duration and re-admission will be followed until one month after end of intervention. Also, patient's quality of life will be measured after one month.
Description: Partial pressure of oxygen in mixed venous blood.
Measure: Mixed venous O2 pressure (PVO2) Time: BaselineDescription: Partial pressure of oxygen in mixed venous blood.
Measure: Mixed venous O2 pressure (PVO2) Time: Day 3Description: Partial pressure of carbon dioxide in mixed venous blood.
Measure: Mixed venous CO2 pressure (PVCO2) Time: BaselineDescription: Partial pressure of carbon dioxide in mixed venous blood.
Measure: Mixed venous CO2 pressure (PVCO2) Time: Day 3Description: Measure of the venous blood acidity or alkalinity
Measure: PH Time: BaselineDescription: Measure of the venous blood acidity or alkalinity
Measure: PH Time: Day 3Description: The amount of bicarbonate ion in the venous blood
Measure: HCO3 Time: BaselineDescription: The amount of bicarbonate ion in the venous blood
Measure: HCO3 Time: Day 3Description: The amount of oxygen-saturated hemoglobin relative to total hemoglobin (unsaturated + saturated) in the venous blood
Measure: Oxygen saturation (O2 Sat) from VBG Time: BaselineDescription: The amount of oxygen-saturated hemoglobin relative to total hemoglobin (unsaturated + saturated) in the venous blood
Measure: Oxygen saturation (O2 Sat) from VBG Time: Day 3Description: The distance a patient can walk during three minute
Measure: Three minute walk test Time: BaselineDescription: The distance a patient can walk during three minute
Measure: Three minute walk test Time: Day 3Description: The number of dead subjects compared to total patients
Measure: Mortality rate Time: until one monthDescription: Patients' hospitalization after discharge due to any reason
Measure: Number of participants with Rehospitalization Time: until one mothDescription: Using Short-form 36 questionnaire. The minimum score is 0 and the maximum score is 100. Higher scores mean patient's better quality of life.
Measure: The Health-Related Quality of Life (HRQOL) Time: One month after end of interventionDescription: The amount of shortness of breath using Visual Analogue Scale (VAS). The minimum score is 0 and maximum is 10. The 0 score means no breathlessness and the 10 score is the maximum breathlessness.
Measure: breathlessness Time: BaselineDescription: The amount of shortness of breath using Visual Analogue Scale (VAS). The minimum score is 0 and maximum is 10. The 0 score means no breathlessness and the 10 score is the maximum breathlessness.
Measure: breathlessness Time: Day 3Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports